They acknowledged limitations including the use of age-based menopausal proxies and the 36-month follow-up window, and called for prospective studies with standardized GLP-1 RA exposure definitions and longer observation periods to validate these findings
11417850000158 Product Details Product Information Other Information Product Details Immune Support, Healthy Radiant Skin Glowing, Antioxidant Support
Mean weight reductions were: 15 mg dose: 20.9 percent 10 mg dose: 19.5 percent 5 mg dose: 15.0 percent Placebo: 3.1 percent At the highest dose, 57 percent of participants lost at least 20 percent of their body weight, and 36 percent lost at least 25 percent [2]
For DPP-4is, most studies reported no association with fracture risk (1525)
This change was significantly greater than the placebo group ( P = 0.016), which tended to lose total non-trunk lean mass by 0.10 kg ( P = 0.560, Fig